Simple eye mask and earplugs may ease anxiety during scary lung procedure

NCT ID NCT07374783

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether wearing an eye mask and earplugs during a fiberoptic bronchoscopy (a tube inserted into the lungs) can lower anxiety and stress. 120 first-time patients will either get the sensory isolation or standard care. Researchers will measure anxiety levels, heart rate, blood pressure, and oxygen levels before, during, and after the procedure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
eye mask and earplugs
What this could lead to
If it works, this could offer a simple, drug-free way to reduce anxiety and stress during medical procedures like bronchoscopy.
What could go wrong
This is a small, early-stage trial with only 120 participants. The effect may be small or not apply to all patients, and anxiety is subjective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2026

An estimate. Start dates often move.

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients undergoing fiberoptic bronchoscopy (FOB) for the first time. * Aged 18 years or older. * Able to read and understand written study materials. * Willing to participate and able to provide written informed consent. * Able to communicate effectively and cooperate during data collection. * Undergoing fiberoptic bronchoscopy under local anesthesia only, without general anesthesia or procedural sedation. Exclusion Criteria: * Patients requiring emergency bronchoscopy. * Patients requiring endotracheal intubation or invasive mechanical ventilation during the procedure. * Patients who withdraw consent or are unable to comply with the study protocol. * Patients with a diagnosed psychiatric disorder that may affect anxiety assessment. * Patients with dementia or other cognitive impairments affecting comprehension or cooperation. * Patients with severe cardiovascular disease, including advanced heart failure. * Individuals with hearing or visual impairments that interfere with the application of sensory isolation procedures. * Patients whose fiberoptic bronchoscopy procedure exceeds 10 minutes in duration.fiberoptic bronchoscopy lasts longer than 10 minutes.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety physiological stress responses ,fiberoptic bronchoscopy, sensory isolation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ege University Faculty of Medicine, Department of Chest Diseases, Bronchoscopy Unit

    Izmir, Turkey (Türkiye)

  • Suat Seren Chest Diseases and Thoracic Surgery Training and Research Hospital

    Izmir, Turkey (Türkiye)